ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.
about
Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancerAnaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication.ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.ALK gene amplification is associated with poor prognosis in colorectal carcinomaALK gene copy number gain and its clinical significance in hepatocellular carcinoma.Biology in prevention and treatment of brain metastases.Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Systemic therapy of brain metastases.The future of targeted therapies for brain metastases.Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.A new look at the ALK gene in cancer: copy number gain and amplification.ALK gene alterations in cancer: biological aspects and therapeutic implications.Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance.Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).Evaluation of tyrosine kinase receptors in brain metastases of clear cell renal cell carcinoma reveals cMet as a negative prognostic factor.Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer.Screening for ALK abnormalities in central nervous system metastases of non-small-cell lung cancer.ROS1 translocations and amplifications in lung cancer brain metastases.ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC.Mechanisms and Therapy for Cancer Metastasis to the Brain.Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis.Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer
P2860
Q26745427-2B7E4571-80BC-4218-959A-6E337E369A88Q35214370-16D6325C-4926-4E1C-A10D-8B8C012EE8C9Q37209474-A94DD76B-540B-462C-9F32-987E5B3D7268Q37323062-3A1E7522-6CE1-42A2-91BC-FBC4F4554616Q37454444-9D10F3D1-D8A7-47D9-8637-87A0AF4B6A6BQ38156192-8E96F471-7482-49DC-8E3B-9BC3E5AE95DCQ38257364-0F52BFB7-0719-4E38-9D90-0C3B912CA169Q38259956-2568C500-395E-4D70-86E9-89032B74819CQ38285931-F60DBD5A-F879-4FBF-8009-DCE0EA46D170Q38564085-E8E42816-1C8E-49FA-A002-A8BA8CE34072Q38649524-09C9DF54-FF91-45C4-899E-890F08466AD3Q38738053-D3294D34-EDEC-42D4-AECD-5DED3FFAD24BQ38760747-6B45F125-951C-4784-855E-97029A6150D9Q38767006-4346FB6C-9A8C-48D3-BB1F-870FA7E01D0BQ38816270-0E369061-AA8F-4604-A755-766E70068088Q39229266-93F6017A-2E72-47FB-B1BD-57F6B4E7CA76Q41108912-0BFBE1A5-213B-4EE8-82FE-9E483664BE8FQ46041746-75AD6836-2F46-49DD-9FDD-679919BE2411Q46562452-9D89EF9F-AEB3-431B-887A-52C81D1D3E94Q48419474-8FB30A26-D997-424D-A15A-F7B6887F560BQ54357706-DC178D38-C46E-4837-99C3-664CB8BE98C4Q54358602-A7D2AD77-720D-4BD4-B226-A4AA017F8325Q54950354-40A2365F-E641-44BB-BB23-A9AB11CBDB57Q55345918-644FD137-D3D3-4A09-B1B5-8EC005A205E8Q58698992-0F10EF91-2E5D-4D28-9341-0D0BC7FB4F29
P2860
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
ALK gene translocations and am ...... of non-small cell lung cancer.
@en
ALK gene translocations and am ...... of non-small cell lung cancer.
@nl
type
label
ALK gene translocations and am ...... of non-small cell lung cancer.
@en
ALK gene translocations and am ...... of non-small cell lung cancer.
@nl
prefLabel
ALK gene translocations and am ...... of non-small cell lung cancer.
@en
ALK gene translocations and am ...... of non-small cell lung cancer.
@nl
P2093
P50
P1433
P1476
ALK gene translocations and am ...... of non-small cell lung cancer
@en
P2093
Adelheid Wöhrer
Ayseguel Ilhan-Mutlu
Berthold Streubel
Carina Dinhof
Christine Marosi
Christoph C Zielinski
Karin Dieckmann
Manuel Magerle
Monika Hackl
Peter Birner
P304
P356
10.1016/J.LUNGCAN.2013.01.019
P577
2013-02-27T00:00:00Z